These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22955795)

  • 1. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.
    de Abajo FJ; Gil MJ; Bryant V; Timoner J; Oliva B; García-Rodríguez LA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):691-701. PubMed ID: 22955795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Lanas A; García-Rodríguez LA; Arroyo MT; Gomollón F; Feu F; González-Pérez A; Zapata E; Bástida G; Rodrigo L; Santolaria S; Güell M; de Argila CM; Quintero E; Borda F; Piqué JM;
    Gut; 2006 Dec; 55(12):1731-8. PubMed ID: 16687434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
    Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
    Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
    Lin KJ; Hernández-Díaz S; García Rodríguez LA
    Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulants.
    Youn SH; Lim H; Ju Y; Soh JS; Park JW; Kang HS; Kim SE; Moon SH; Kim JH; Park CK; Seo SI; Shin WG
    Scand J Gastroenterol; 2018 Dec; 53(12):1490-1495. PubMed ID: 30509124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model to predict the risk of aspirin/non-steroidal anti-inflammatory drugs-related upper gastrointestinal bleeding for the individual patient.
    Petersen J; Møller Hansen J; de Muckadell OBS; Dall M; Hallas J
    Basic Clin Pharmacol Toxicol; 2020 May; 126(5):437-443. PubMed ID: 31765070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.
    Laporte JR; Ibáñez L; Vidal X; Vendrell L; Leone R
    Drug Saf; 2004; 27(6):411-20. PubMed ID: 15144234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
    Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
    J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.
    Nagata N; Niikura R; Yamada A; Sakurai T; Shimbo T; Kobayashi Y; Okamoto M; Mitsuno Y; Ogura K; Hirata Y; Fujimoto K; Akiyama J; Uemura N; Koike K
    PLoS One; 2016; 11(3):e0151332. PubMed ID: 26978517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database.
    Yamate S; Ishiguro C; Fukuda H; Hamai S; Nakashima Y
    PLoS One; 2024; 19(6):e0305320. PubMed ID: 38861561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of upper gastrointestinal bleeding from different drug combinations.
    Masclee GM; Valkhoff VE; Coloma PM; de Ridder M; Romio S; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Kuipers EJ; van der Lei J; Sturkenboom MC
    Gastroenterology; 2014 Oct; 147(4):784-792.e9; quiz e13-4. PubMed ID: 24937265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.
    García Rodríguez LA; Jick H
    Lancet; 1994 Mar; 343(8900):769-72. PubMed ID: 7907735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.